80 results
8-K
EX-10.1
COGT
Cogent Biosciences Inc
22 Mar 24
Unregistered Sales of Equity Securities
8:33am
than the close of business on the second business day after the date hereof (the “Closing Date”) and subject to the satisfaction or waiver
S-8
EX-5.1
COGT
Cogent Biosciences Inc
26 Feb 24
Registration of securities for employees
4:34pm
, or copies certified or otherwise identified to our satisfaction as being true and complete copies of the originals, of such documents, corporate records
8-K
EX-3.1
COGT
Cogent Biosciences Inc
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
(in an open market transaction or otherwise), or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale … established to the satisfaction of the Corporation that such tax has been paid.
6.6 Status as Stockholder. Upon each Conversion Date, (i) the shares
8-K
EX-99.1
4tc39q 0f
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
8-K
EX-10.1
lnvmdv9 m5bk1cc
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
S-8
EX-5.1
w9b2c26csvwpr h5
8 Aug 23
Registration of securities for employees
4:31pm
8-K
EX-1.1
uw9k70u75 jyb1yd2
8 Jun 23
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-5.1
v94qa0
8 Jun 23
Entry into a Material Definitive Agreement
4:31pm
424B5
137tb
8 Jun 23
Prospectus supplement for primary offering
4:01pm
8-K
EX-10.1
bwb8a iputvhnnugo
7 Jun 23
Departure of Directors or Certain Officers
4:24pm
424B5
scf 29bth1
6 Jun 23
Prospectus supplement for primary offering
5:22pm
8-K/A
EX-4.1
w9vbh
16 Jun 22
Entry into a Material Definitive Agreement
5:03pm